LY900003
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for LY900003, covering 2006-07-19 to 2006-07-19. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 3 Trial of LY900003 Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer [Phase 3]